查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1666715

婴儿配方奶粉 DHA 藻油市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

Infant Formula DHA Algae Oil Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 235 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年全球婴儿配方奶粉 DHA 藻类油市场价值为 3.672 亿美元，预计 2025 年至 2034 年的复合年增长率将达到 7%。随着消费者越来越重视更健康的饮食选择，富含 DHA 的产品（如婴儿配方奶粉、膳食补充剂和功能性食品）正迅速受到欢迎。父母尤其热衷于确保孩子的大脑和视力得到最佳发育，这导致对富含 DHA 的产品的需求激增。此外，植物性 DHA 来源（尤其是藻类油）的日益普及进一步激发了消费者的兴趣，因为这符合永续性和环保意识日益增强的趋势。对植物性 DHA 的偏好，加上油萃取技术的进步，确保了市场持续扩张。

婴儿配方奶粉 DHA 藻油市场 - IMG1

DHA 藻类油市场根据 DHA 浓度分为两个主要类别：30%-40% 和 40%-50%。 40%-50% 浓度细分市场规模最大，2024 年市场价值为 1.225 亿美元。这种需求源于人们越来越认识到 DHA 在认知、视觉和免疫系统健康方面的重要作用，尤其是在儿童发展的早期阶段。父母比以往任何时候都更了解情况，可以做出有意识的决定，为孩子提供尽可能最有效的营养支持。

市场范围
起始年份 2024
预测年份 2025-2034
起始值 3.672亿美元
预测值 7.348 亿美元
复合年增长率 7%

市场区隔还包括0-3岁、3-6岁等年龄组，以及其他组别，包括早产儿和大龄儿童。 0-3 年期市场占据主导地位，到 2024 年份额将达到 96.9%，并且继续保持最快的成长速度。婴幼儿有特殊的营养需求，这对于大脑发育、视力健康和免疫系统增强至关重要。富含 DHA 的配方奶粉在满足这些需求方面发挥着不可或缺的作用，并且随着对这些益处的认识不断提高，对注入 DHA 的婴儿配方奶粉的需求将会飙升。

在美国，2024 年婴儿配方奶粉中 DHA 藻油的市场规模将达到 2,230 万美元。此外，家长们对 DHA 在儿童早期发展中的重要性的认识不断加深，这也导致优质配方奶粉的采用率不断提高。高可支配收入水平，加上电子商务等完善的分销管道，使得美国消费者更容易买到这些产品。

目录

第 1 章：方法论与范围

  • 市场范围和定义
  • 基础估算与计算
  • 预测计算
  • 资料来源
    • 基本的
    • 次要
      • 付费来源
      • 公共资源

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
    • 影响价值链的因素
    • 利润率分析
    • 中断
    • 未来展望
    • 製造商
    • 经销商
  • 供应商概况
  • 利润率分析
  • 重要新闻及倡议
  • 监管格局
  • 衝击力
    • 成长动力
      • 母乳替代需求不断成长
      • 有利的监管前景
      • 婴儿食品业大幅扩张
    • 产业陷阱与挑战
      • 原物料价格波动
      • DHA 对婴儿有益的科学证据相互矛盾
  • 成长潜力分析
  • 波特的分析
  • PESTEL 分析

第四章：竞争格局

  • 介绍
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略展望矩阵

第 5 章：市场估计与预测：按内容，2021 年至 2034 年

  • 主要趋势
  • 30% - 40%
  • 40% - 50%

第 6 章：市场估计与预测：依最终用途，2021 年至 2034 年

  • 主要趋势
  • 0 – 3 岁
  • 3 – 6 岁
  • 其他（早产儿，7岁以上）

第 7 章：市场估计与预测：按地区，2021 年至 2034 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 俄罗斯
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 墨西哥
  • 中东及非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第八章：公司简介

  • Algarithm
  • Cellana
  • Far East Microalgae
  • Goerlich Pharma
  • Guangdong Runke Bio-Engineering
  • Henry Lamotte OILS
  • Hubei Fuxing Biotechnology
  • JC Biotech
  • Kingdomway Nutrition
  • Lonza
  • Meteoric Biopharmaceutical
  • Nordic Naturals
  • Polaris
  • Qingdao Keyuan Marine Biochemistry
  • Xiamen Huison Biotech
简介目录
Product Code: 4832

The Global Infant Formula DHA Algae Oil Market was valued at USD 367.2 million in 2024, with projections indicating a robust CAGR of 7% from 2025 to 2034. This growth can be largely attributed to a growing awareness of the numerous health benefits associated with DHA, a crucial omega-3 fatty acid. As consumers continue to prioritize healthier dietary choices, products enriched with DHA, such as infant formulas, dietary supplements, and functional foods, are rapidly gaining popularity. Parents are particularly keen on ensuring optimal brain and vision development for their children, leading to a surge in demand for DHA-enriched products. Furthermore, the increasing availability of plant-based DHA sources, particularly algae oil, has further driven consumer interest, as it aligns with the growing trend of sustainability and environmental consciousness. This preference for plant-based DHA, alongside advancements in oil extraction technology, ensures the market's continued expansion.

Infant Formula DHA Algae Oil Market - IMG1

The DHA algae oil market is segmented by DHA concentration into two primary categories: 30%-40% and 40%-50%. The 40%-50% concentration segment is the largest, generating USD 122.5 million in 2024. It is also the fastest-growing segment, with an increasing number of parents opting for formulas with higher DHA content. This demand is driven by a stronger recognition of DHA's vital role in cognitive, visual, and immune system health, particularly during the early stages of a child's development. Parents are more informed than ever, making conscious decisions to provide their children with the most effective nutritional support possible.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$367.2 Million
Forecast Value$734.8 Million
CAGR7%

Market segmentation also includes age groups such as 0-3 years, 3-6 years, and other groups, which include premature infants and older children. The 0-3 years segment dominated the market with a share of 96.9% in 2024, and it continues to see the fastest growth. Infants and toddlers have specific nutritional needs that are crucial for brain development, visual health, and immune system strengthening. DHA-enriched formulas play an integral role in meeting these needs, and as awareness of these benefits increases, the demand for DHA-infused infant formulas is set to soar.

In the U.S., the market for DHA algae oil in infant formulas accounted for USD 22.3 million in 2024. This growth is supported by regulatory frameworks, such as recommendations from the FDA and WHO, which require the inclusion of DHA in infant formulas. Additionally, parents' growing understanding of DHA's importance in early childhood development has led to increased adoption of premium formulas. High disposable income levels, coupled with well-established distribution channels, including e-commerce, have made these products more accessible to American consumers.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculations
  • 1.4 Data sources
    • 1.4.1 Primary
    • 1.4.2 Secondary
      • 1.4.2.1 Paid sources
      • 1.4.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry synopsis, 2021-2034

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Factor affecting the value chain
    • 3.1.2 Profit margin analysis
    • 3.1.3 Disruptions
    • 3.1.4 Future outlook
    • 3.1.5 Manufacturers
    • 3.1.6 Distributors
  • 3.2 Supplier landscape
  • 3.3 Profit margin analysis
  • 3.4 Key news & initiatives
  • 3.5 Regulatory landscape
  • 3.6 Impact forces
    • 3.6.1 Growth drivers
      • 3.6.1.1 Growing demand for breast milk substitutes
      • 3.6.1.2 Favorable regulatory outlook
      • 3.6.1.3 Significant expansion of the baby food industry
    • 3.6.2 Industry pitfalls & challenges
      • 3.6.2.1 Price volatility of raw material
      • 3.6.2.2 Contradictory scientific evidence of DHA benefits in infants
  • 3.7 Growth potential analysis
  • 3.8 Porter’s analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategic outlook matrix

Chapter 5 Market Estimates & Forecast, By Content, 2021-2034 (USD Million) (Tons)

  • 5.1 Key trends
  • 5.2 30% - 40%
  • 5.3 40% - 50%

Chapter 6 Market Estimates & Forecast, By End Use, 2021-2034 (USD Million) (Tons)

  • 6.1 Key trends
  • 6.2 0 – 3 years old
  • 6.3 3 – 6 years old
  • 6.4 Others (premature infants, 7+ years old)

Chapter 7 Market Estimates & Forecast, By Region, 2021-2034 (USD Million) (Tons)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 UK
    • 7.3.2 Germany
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Russia
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 India
    • 7.4.3 Japan
    • 7.4.4 South Korea
    • 7.4.5 Australia
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
  • 7.6 MEA
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE

Chapter 8 Company Profiles

  • 8.1 Algarithm
  • 8.2 Cellana
  • 8.3 Far East Microalgae
  • 8.4 Goerlich Pharma
  • 8.5 Guangdong Runke Bio-Engineering
  • 8.6 Henry Lamotte OILS
  • 8.7 Hubei Fuxing Biotechnology
  • 8.8 JC Biotech
  • 8.9 Kingdomway Nutrition
  • 8.10 Lonza
  • 8.11 Meteoric Biopharmaceutical
  • 8.12 Nordic Naturals
  • 8.13 Polaris
  • 8.14 Qingdao Keyuan Marine Biochemistry
  • 8.15 Xiamen Huison Biotech